Featured ArticlesPsoriasis

Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature

By August 27, 2020No Comments

Featured Article

Featured Article

The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popularization of a variety of cannabinoid preparations including topical forms such as creams, salves, lotions, lubricants, and many others.

Read more

This report details a case of a young man with psoriasis managed with topical cannabinoids.

Adam J. Friedman MD, Kimia Momeni BS, Mikhail Kogan MD

 

The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popularization of a variety of cannabinoid preparations including topical forms such as creams, salves, lotions, lubricants, and many others.

However, while the market is exponentially growing, the rate at which mechanistic and clinical evidence supporting the use of cannabinoids in a litany of diseases is significantly slower. In fact, Robinson et al highlighted significant gaps in dermatologists understanding of the biology of cannabinoids and comfort with this space, further highlighting the great need to disseminate information throughout the medical community.

Along this vein, we present a case of a young man with psoriasis managed with topical cannabinoids.

View Case Study Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About Injectable Minoxidil for Hair Loss Disorders: A Systematic Review

Injectable Minoxidil for Hair Loss Disorders: A Systematic Review

| Featured Articles, The Latest | No Comments
JDD Latest News Could injectable minoxidil revolutionize hair loss management? While widely used in topical and oral forms, its injectable counterpart is garnering attention for treating conditions like androgenetic alopecia and…
Journal of Drugs in Dermatology JDD Article About Practical Update on Treatment of Oral Candidiasis

Practical Update on Treatment of Oral Candidiasis

| Featured Articles, The Latest | No Comments
JDD Online Exclusive As new psoriasis treatments expand, so do potential side effects like oral candidiasis. This common yet manageable condition may present with distinctive symptoms, such as burning sensations or…
Journal of Drugs in Dermatology JDD Article About Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management Subspecialty

Recognizing and Advancing Leadership in Dermatology: Promoting the Health Care Administration, Leadership, and Management Subspecialty

| Featured Articles, The Latest | No Comments
JDD Article Highlights The launch of the Health Care Administration Leadership and Management (HALM) subspecialty in 2023 is poised to redefine leadership in dermatology. Supported by the American Board of…

Leave a Reply